Raymond James lowered the firm’s price target on Crescent Capital BDC (CCAP) to $17 from $20 and keeps an Outperform rating on the shares. While fourth quarter results were well below the firm’s estimates, Raymond James continues to see an attractive risk/reward, with a conservatively implemented variable dividend policy, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCAP:
- Crescent Capital BDC price target lowered to $15 from $16 at Wells Fargo
- Crescent Capital downgraded to Market Perform from Outperform at Keefe Bruyette
- Crescent Capital BDC Reports Q1 2025 Earnings
- Crescent Capital BDC Navigates Earnings Amid Challenges
- Cooperman’s Omega buys Sunoco, exits Arbor and Blue Owl in Q1